itraconazole has been researched along with Leukemia, Myeloid, Acute in 65 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.54) | 18.7374 |
1990's | 12 (18.46) | 18.2507 |
2000's | 19 (29.23) | 29.6817 |
2010's | 27 (41.54) | 24.3611 |
2020's | 6 (9.23) | 2.80 |
Authors | Studies |
---|---|
Colunga-Pedraza, PR; De la Garza-Salazar, F; Gómez-Almaguer, D; Peña-Lozano, SP | 1 |
Kobayashi, M; Kosugi, N; Suzaki, K; Yasu, T | 1 |
Baker, SD; Eisenmann, ED; Garrison, DA; Hu, S; Jin, Y; Sparreboom, A; Talebi, Z | 1 |
Almeida-Paes, R; Hidalgo, JED; Jardim, LS; Poester, VR; Rabello, VBS; Trápaga, MR; Xavier, MO; Zancope-Oliveira, RM | 1 |
Athans, V; Brizendine, KD; Cober, E; Copley, MS; Siebenaller, C; Waldron, M; Welch, SC | 1 |
Fan, B; Ke, A; Le, K; Prakash, C; Yang, H | 1 |
Aragón, B; Cámara, R; Gozalbo, I; Grau, S; Jurado, M; Sanz, J | 1 |
Amat, P; Calabuig, M; Hernández-Boluda, JC; Navarro, D; Pérez-Martínez, A; Solano, C; Tormo, M | 1 |
Ader, F; Aguado, JM; Akova, M; Arendrup, MC; Arikan-Akdagli, S; Barnes, RA; Beigelman-Aubry, C; Blot, S; Bouza, E; Brüggemann, RJM; Buchheidt, D; Cadranel, J; Castagnola, E; Chakrabarti, A; Cornely, OA; Cuenca-Estrella, M; Denning, DW; Dimopoulos, G; Fortun, J; Gangneux, JP; Garbino, J; Groll, AH; Heinz, WJ; Herbrecht, R; Heussel, CP; Kibbler, CC; Klimko, N; Kullberg, BJ; Lagrou, K; Lange, C; Lass-Flörl, C; Lehrnbecher, T; Lewis, RE; Löffler, J; Lortholary, O; Maertens, J; Marchetti, O; Meis, JF; Munoz, P; Pagano, L; Ribaud, P; Richardson, M; Roilides, E; Ruhnke, M; Sanguinetti, M; Sheppard, DC; Sinkó, J; Skiada, A; Ullmann, AJ; Vehreschild, MJGT; Verweij, PE; Viscoli, C; Warris, A | 1 |
Ancer-Arellano, J; Barboza-Quintana, O; Cardenas-de la Garza, JA; Cuellar-Barboza, A; Gallardo-Rocha, A; Ocampo-Candiani, J; Ocampo-Garza, SS; Saenz-Ibarra, B; Vera-Cabrera, L; Welsh, O | 1 |
Agresta, S; Bowden, C; Dai, D; Fan, B; Hickman, D; Liu, G; Liu, H; Nabhan, S; Prakash, C; Vutikullird, A; Yang, H; Zacher, J | 1 |
Feng, SZ; Han, MZ; He, Y; Huang, Y; Liu, X; Ma, QL; Pang, AM; Wei, JL; Yang, DL | 1 |
Allione, B; Audisio, E; Aydin, S; Barbui, AM; Busca, A; D'Ardia, S; De Rosa, FG; Dellacasa, CM; Falda, M; Frairia, C; Manetta, S; Marmont, F; Pecoraro, C; Vitolo, U | 1 |
Åkerborg, Ö; Björkholm, M; Höglund, M; Lundberg, J | 1 |
Guo, K; Wang, J; Xu, X; Zhou, R | 1 |
Abdul Halim, NA; Tan, BH; Wong, GC | 1 |
Pagano, L; Tumbarello, M | 1 |
Back, H; Cho, SY; Choi, JH; Choi, JK; Choi, SM; Kang, S; Kim, HJ; Kim, SH; Kim, YJ; Lee, DG; Lee, EK; Lee, HJ; Min, WS; Park, SH; Yoo, JH | 1 |
Chan, TS; Gill, H; Hwang, YY; Kwong, YL; Marcella, SW | 1 |
Chai, LY; Khoo, AL; Lim, BP; Ong, B; Tan, BH; Tan, G; Tee, C; Teng, M; Zhao, YJ | 1 |
Audisio, E; Aversa, F; Bruno, B; Busca, A; Candoni, A; Delia, M; Monaco, F; Mordini, N; Pagano, L; Passera, R; Vacca, A | 1 |
Keighley, CL; Larsen, SR; Manii, P; van Hal, S | 1 |
Eto, T; Henzan, H; Jinnochi, F; Jiromaru, T; Kawano, I; Matsumoto, K; Morita, K; Saito, N; Sakamoto, K; Semba, Y; Sugio, T; Takase, K; Yoshida, S | 1 |
Karthaus, M | 1 |
Jansen, JP; Janssen, JJ; Lugtenburg, E; O'Sullivan, AK; Rijnders, B; Span, LF; Stam, WB | 1 |
Alvarado, G; Blamble, D; Cortes, J; Faderl, S; Hernandez, M; Kantarjian, H; Koller, C; Mattiuzzi, GN; Pierce, S; Verstovsek, S; Xiao, L | 1 |
Lazzaro, C | 1 |
Cutlan, JE; Geddes, ER; Hymes, SR; Polder, K; Torres-Cabala, CA | 1 |
Dranitsaris, G; Khoury, H | 1 |
Katayama, Y; Murayama, SY; Myoken, Y; Sugata, T | 1 |
Ananda-Rajah, MR; Bajel, A; Cheng, A; Downey, MT; Grigg, A; Slavin, MA; Spelman, T; Thursky, KT; Vincent, J | 1 |
Andrade M, A; Capurro C, M; Guerra C, C; Molina E, J; Puga L, B | 1 |
Bartolesi, AM; Fanci, R; Pecile, P; Pini, G | 1 |
Aversa, F; Busca, A; Caira, M; Candoni, A; Caramatti, C; Castagnola, C; Cattaneo, C; De Paolis, MR; Delia, M; Di Blasi, R; Di Caprio, L; Fanci, R; Garzia, M; Martino, B; Melillo, L; Mitra, ME; Nadali, G; Nosari, A; Pagano, L; Picardi, M; Potenza, L; Salutari, P; Trecarichi, EM; Tumbarello, M; Verga, L; Vianelli, N | 1 |
Ando, K; Fukushima, T; Hata, T; Honda, S; Imaizumi, Y; Imanishi, D; Itonaga, H; Matsuo, E; Miyazaki, Y; Moriuchi, Y; Onimaru, Y; Sato, S; Sawayama, Y; Taguchi, J; Tsushima, H; Yamasaki, R; Yoshida, S | 1 |
Beran, M; Cortes, J; Estey, E; Giles, F; Kantarjian, H; Koller, C; Kontoyiannis, D; Mattiuzzi, GN; Munsell, M; Raad, I; Shen, Y | 1 |
Fujihara, M; Fujita, Y; Katsu, M; Kyo, T; Mikami, Y; Myoken, Y; Sugata, T | 1 |
Ashihara, E; Fuchida, S; Fujita, N; Inaba, T; Nakagawa, M; Ochiai, N; Okano, A; Shimazaki, C; Uchida, R | 1 |
Khoury, H; Lavoie, JC; Nevill, TJ; Poh, CF; Williams, M | 1 |
Bekele, BN; Cortes, J; Estey, E; Faderl, S; Giles, F; Kantarjian, H; Kontoyiannis, DP; Leitz, GJ; Lim, J; Mattiuzzi, GN; O'Brien, S; Pierce, S; Raad, I; Zhou, X | 1 |
Brochhagen, HG; Chemnitz, J; Cornely, OA; Hübel, K | 1 |
Nakagawa, Y | 1 |
Angulo-Gonzalez, D; Cornely, OA; Goh, YT; Hardalo, C; Helfgott, D; Holowiecki, J; Maertens, J; Perfect, J; Petrini, M; Stockelberg, D; Suresh, R; Ullmann, AJ; Walsh, TJ; Winston, DJ | 1 |
Aoyama, Y; Ito, Y; Kanamaru, A; Kiguchi, T; Masaoka, T; Matsuda, M; Matsuura, Y; Mugitani, A; Ohyashiki, K; Sakamoto, E; Takeuchi, M; Tamura, K; Urabe, A; Wakita, H; Yoshida, I | 1 |
Bellmann, R; Weiler, S | 1 |
van Dissel, JT; van Nieuwkoop, C | 1 |
Ağirbasli, H; Bilgen, H; Can, E; Cerikçioğlu, N; Durmaz, R; Gedikoğlu, G; Otlu, B; Ozcan, SK; Sinik, G; Sugita, T; Yalman, N | 1 |
Gyarfás, J; Kollár, T; Krcméry, V; Kunová, A; Spánik, S | 1 |
Altés, A; Brunet, S; Domingo-Albós, A; Martínez, C; Martino, R; Nomdedéu, J; Sureda, A | 1 |
Baro, J; Conde, E; Insunza, A; Iriondo, A; Loyola, I; Richard, C; Romón, I; Tapia, M; Zubizarreta, A; Zurbano, F | 1 |
de Pauw, BE; Raemaekers, JM; van Dijke, BJ; Vreugdenhil, G | 1 |
Bergfeld, WF; Bolwell, BJ; Helm, TN; Ruxin, TA; Steck, WD | 1 |
Fujihara, M; Kyo, T; Myoken, Y; Sugata, T | 1 |
Comito, MA; Rumelhart, SL; Trigg, ME | 1 |
Prentice, AG; Warnock, DW | 1 |
Fujihara, M; Kyo, T; Mikami, Y; Myoken, Y; Sugata, T | 2 |
Hinrichs, SH; Iwen, PC; Lackner, RP; McCarthy, DI; Rinaldi, MG; Sigler, L; Sutton, DA; Tarantolo, S | 1 |
Cottoni, F; Sanna, S; Satta, R | 1 |
Baba, H; Iwasaki, H; Maezawa, Y; Takagi, K; Tsutani, H; Ueda, T; Yamashita, T; Yamauchi, T; Yoshida, A | 1 |
Miyanishi, E; Nakase, K; Shiku, H; Tamaki, S; Tanigawa, M; Tsuji, K; Yazaki, A | 1 |
Atkinson, K; Enno, A; Walsh, M; White, L | 1 |
Hendriks, WD; Sizoo, W | 1 |
Bradford, CR; Copplestone, JA; Prentice, AG; Warnock, DW | 1 |
Cohen, O; De Pauw, BE; De Vries, F; De Witte, T; Donnelly, JP; Schattenberg, A | 1 |
2 review(s) available for itraconazole and Leukemia, Myeloid, Acute
Article | Year |
---|---|
Network Meta-analysis and Pharmacoeconomic Evaluation of Fluconazole, Itraconazole, Posaconazole, and Voriconazole in Invasive Fungal Infection Prophylaxis.
Topics: Adult; Antifungal Agents; Aspergillus; Candida; Cost-Benefit Analysis; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Economic; Mycoses; Singapore; Survival Analysis; Triazoles; Voriconazole | 2016 |
Pseudallescheria boydii in an immunocompromised host. Successful treatment with debridement and itraconazole.
Topics: Antifungal Agents; Combined Modality Therapy; Debridement; Foot Dermatoses; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycetoma; Pseudallescheria | 1996 |
10 trial(s) available for itraconazole and Leukemia, Myeloid, Acute
Article | Year |
---|---|
Effect of itraconazole, food, and ethnic origin on the pharmacokinetics of ivosidenib in healthy subjects.
Topics: Administration, Oral; Adult; Antineoplastic Agents; Area Under Curve; Asian People; Cross-Over Studies; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Female; Food-Drug Interactions; Glycine; Healthy Volunteers; Humans; Itraconazole; Leukemia, Myeloid, Acute; Long QT Syndrome; Male; Middle Aged; Pyridines | 2019 |
[Prophylaxis of invasive fungal infection with different administration regimens of itraconazole in patients with acute myeloid leukemia: a report from a randomized, controlled trial].
Topics: Adolescent; Adult; Antibiotic Prophylaxis; Antifungal Agents; Female; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Young Adult | 2013 |
Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Bilirubin; Drug Monitoring; Female; Humans; Infusions, Intravenous; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2011 |
[Economic evaluation of posaconazole in prophylaxis of invasive fungal infections in Italian neutropenic patients with acute myeloid leukaemia or myelodysplastic syndrome].
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cost-Benefit Analysis; Deoxycholic Acid; Drug Combinations; Drug Costs; Equipment and Supplies; Fluconazole; Follow-Up Studies; Hospital Costs; Humans; Immunocompromised Host; Infusions, Intravenous; Italy; Itraconazole; Leukemia, Myeloid, Acute; Mycoses; Myelodysplastic Syndromes; Neutropenia; Oncology Nursing; Treatment Outcome; Triazoles | 2010 |
Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry.
Topics: Aged; Antifungal Agents; Female; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Triazoles | 2012 |
Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Drug Therapy, Combination; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Liposomes; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Opportunistic Infections; Prospective Studies; Survival Analysis | 2003 |
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Female; Fluconazole; Humans; Itraconazole; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Opportunistic Infections; Single-Blind Method; Treatment Outcome; Triazoles | 2007 |
The prophylactic effect of itraconazole capsules and fluconazole capsules for systemic fungal infections in patients with acute myeloid leukemia and myelodysplastic syndromes: a Japanese multicenter randomized, controlled study.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Capsules; Female; Fluconazole; Humans; Itraconazole; Japan; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes | 2007 |
Itraconazole and multidrug resistance: possible effects on remission rate and disease-free survival in acute leukemia.
Topics: Adolescent; Adult; Drug Resistance; Female; Humans; Itraconazole; Ketoconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Survival Rate | 1993 |
Comparison of the multiple dose pharmacokinetics of two formulations of itraconazole during remission induction for acute myeloblastic leukaemia.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Humans; Itraconazole; Ketoconazole; Leukemia, Myeloid, Acute; Middle Aged; Polyethylene Glycols; Powders; Remission Induction; Solutions | 1991 |
53 other study(ies) available for itraconazole and Leukemia, Myeloid, Acute
Article | Year |
---|---|
Orbital myeloid sarcoma treated with low-dose venetoclax and a potent cytochrome P450 inhibitor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytochrome P-450 Enzyme System; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Sarcoma; Sarcoma, Myeloid | 2023 |
Utility of therapeutic drug monitoring of venetoclax in acute myeloid leukemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bridged Bicyclo Compounds, Heterocyclic; Cytarabine; Cytochrome P-450 CYP3A Inhibitors; Drug Monitoring; Humans; Itraconazole; Leukemia, Myeloid, Acute; Sulfonamides | 2022 |
Itraconazole-Induced Increases in Gilteritinib Exposure Are Mediated by CYP3A and OATP1B.
Topics: Aniline Compounds; Animals; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Itraconazole; Leukemia, Myeloid, Acute; Mice; Protein Kinase Inhibitors | 2022 |
Amlodipine and lufenuron as repurposing drugs against
Topics: Amlodipine; Antifungal Agents; Drug Repositioning; Humans; Itraconazole; Leukemia, Myeloid, Acute | 2023 |
Itraconazole vs. posaconazole for antifungal prophylaxis in patients with acute myeloid leukemia undergoing intensive chemotherapy: A retrospective study.
Topics: Adult; Antifungal Agents; Antineoplastic Agents; Humans; Invasive Fungal Infections; Itraconazole; Leukemia, Myeloid, Acute; Retrospective Studies; Triazoles | 2020 |
Physiologically based pharmacokinetic modeling and simulation to predict drug-drug interactions of ivosidenib with CYP3A perpetrators in patients with acute myeloid leukemia.
Topics: Administration, Oral; Antineoplastic Agents; Area Under Curve; Computer Simulation; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Fluconazole; Glycine; Healthy Volunteers; Humans; Itraconazole; Ketoconazole; Leukemia, Myeloid, Acute; Male; Microsomes, Liver; Models, Biological; Pyridines; Rifampin | 2020 |
Cost-Effectiveness of Posaconazole Tablets for Invasive Fungal Infections Prevention in Acute Myelogenous Leukemia or Myelodysplastic Syndrome Patients in Spain.
Topics: Adult; Aged; Antifungal Agents; Cost-Benefit Analysis; Female; Fluconazole; Humans; Invasive Fungal Infections; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Economic; Myelodysplastic Syndromes; Solutions; Spain; Tablets; Triazoles | 2017 |
Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing intensive cytotoxic chemotherapy: A real-world comparison.
Topics: Adult; Aged; Antifungal Agents; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Invasive Fungal Infections; Invasive Pulmonary Aspergillosis; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Pre-Exposure Prophylaxis; Retrospective Studies; Treatment Failure; Triazoles | 2018 |
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Biopsy; Bronchoalveolar Lavage; Disease Management; Early Diagnosis; Flucytosine; Galactose; Humans; Immunocompromised Host; Immunologic Tests; Invasive Pulmonary Aspergillosis; Itraconazole; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Mannans; Microbial Sensitivity Tests; Myelodysplastic Syndromes; Nitriles; Pyridines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2018 |
Disseminated Trichosporon asahii infection in a patient with acute myeloid leukemia.
Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Biopsy; Fatal Outcome; Female; Fungemia; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myeloid, Acute; Middle Aged; Skin; Treatment Failure; Trichosporon; Trichosporonosis | 2019 |
Prevention of invasive fungal infections in patients with acute myeloid leukaemia: results of a single centre retrospective observational study with the use of posaconazole versus conventional mould-active azoles.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Cohort Studies; Female; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Retrospective Studies; Triazoles; Young Adult | 2014 |
Economic evaluation of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infection in high-risk neutropenic patients in Sweden.
Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Life Expectancy; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Quality of Life; Quality-Adjusted Life Years; Sweden; Triazoles | 2014 |
[Effects of itraconazole plus doxorubicin on proliferation and apoptosis in acute myeloid leukemia cells].
Topics: Apoptosis; Cell Proliferation; Doxorubicin; Hedgehog Proteins; Humans; Itraconazole; Leukemia, Myeloid, Acute; Signal Transduction; Tumor Cells, Cultured | 2015 |
Antifungal Prophylaxis With Posaconazole Is Effective in Preventing Invasive Fungal Infections in Acute Myeloid Leukemia Patients During Induction and Salvage Chemotherapy.
Topics: Antifungal Agents; Female; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Mycoses; Triazoles | 2015 |
Reply to Wong et al.
Topics: Antifungal Agents; Female; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Mycoses; Triazoles | 2015 |
Cost-benefit Analysis of Posaconazole Versus Fluconazole or Itraconazole as a Primary Antifungal Prophylaxis in High-risk Hematologic Patients: A Propensity Score-matched Analysis.
Topics: Adult; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Cost Savings; Cost-Benefit Analysis; Drug Costs; Female; Fluconazole; Hospital Costs; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Primary Prevention; Propensity Score; Remission Induction; Republic of Korea; Retrospective Studies; Triazoles | 2015 |
Posaconazole vs fluconazole or itraconazole for prevention of invasive fungal diseases in patients with acute myeloid leukemia or myelodysplastic syndrome: a cost-effectiveness analysis in an Asian teaching hospital.
Topics: Antifungal Agents; Cost-Benefit Analysis; Decision Support Techniques; Fluconazole; Hong Kong; Hospitals, Teaching; Humans; Itraconazole; Leukemia, Myeloid, Acute; Models, Econometric; Mycoses; Myelodysplastic Syndromes; Socioeconomic Factors; Triazoles | 2016 |
Long-Lasting Protective Effect of Posaconazole Prophylaxis in Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
Topics: Adolescent; Adult; Aged; Allografts; Antifungal Agents; Blood Donors; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Invasive Fungal Infections; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Premedication; Salvage Therapy; Survival Analysis; Triazoles; Young Adult | 2016 |
Clinical effectiveness of itraconazole as antifungal prophylaxis in AML patients undergoing intensive chemotherapy in the modern era.
Topics: Adult; Aged; Antifungal Agents; Chemoprevention; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Treatment Outcome | 2017 |
Significance of monitoring trough plasma concentration levels for invasive fungal infection prophylaxis with itraconazole oral solution in patients with hematological malignancies: a prospective study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Fungi; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Prospective Studies; Young Adult | 2016 |
Treatment of aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neutropenia; Triazoles | 2008 |
Economic evaluation of posaconazole vs. standard azole prophylaxis in high risk neutropenic patients in the Netherlands.
Topics: Adult; Aged; Antifungal Agents; Costs and Cost Analysis; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Econometric; Mycoses; Myelodysplastic Syndromes; Netherlands; Neutropenia; Randomized Controlled Trials as Topic; Triazoles | 2008 |
Ulcerated plaque under a ruby ring in an immunosuppressed patient.
Topics: Adenine Nucleotides; Aged; Antineoplastic Agents; Arabinonucleosides; Candida; Candidiasis, Cutaneous; Clofarabine; Cytarabine; Dermatologic Agents; Dermatomycoses; Fusarium; Humans; Immunocompromised Host; Itraconazole; Jewelry; Leukemia, Myeloid, Acute; Male; Pyrimidines; Skin Ulcer; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Posaconazole versus fluconazole or itraconazole for prevention of invasive fungal infections in patients undergoing intensive cytotoxic therapy for acute myeloid leukemia or myelodysplasia: a cost effectiveness analysis.
Topics: Antifungal Agents; Antineoplastic Agents; Canada; Cost Savings; Cost-Benefit Analysis; Decision Support Techniques; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Models, Economic; Mycoses; Myelodysplastic Syndromes; Neoplasms; Randomized Controlled Trials as Topic; Triazoles | 2011 |
Prompt and definitive diagnosis of acute invasive Aspergillus rhinosinusitis in a patient with acute myeloid leukaemia using in situ hybridization: a case report.
Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillus; Cytarabine; Humans; Idarubicin; In Situ Hybridization; Itraconazole; Leukemia, Myeloid, Acute; Male; Mycological Typing Techniques; Rhinitis; Sinusitis | 2012 |
Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Medication Adherence; Middle Aged; Mycoses; Myelodysplastic Syndromes; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2012 |
[Itraconazole 800 mg for the prophylaxis of fungal infections in patients with acute leukemia and severe neutropenia].
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Female; Fever; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Pulmonary Aspergillosis; Young Adult | 2011 |
Refractory disseminated fusariosis by Fusarium verticillioides in a patient with acute myeloid leukaemia relapsed after allogeneic hematopoietic stem cell transplantation: a case report and literature review.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Drug Resistance, Multiple, Fungal; Etoposide; Fatal Outcome; Female; Fusariosis; Fusarium; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myeloid, Acute; Mitoxantrone; Neutropenia; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Premedication; Pyrimidines; Recurrence; Salvage Therapy; Transplantation, Homologous; Triazoles; Voriconazole | 2013 |
Distinct clinical features of infectious complications in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis in the Nagasaki transplant group.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Bacterial Infections; Cytomegalovirus Infections; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Japan; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Survival Analysis; Transplantation, Homologous | 2013 |
Successful treatment of invasive stomatitis due to Exophiala dermatitidis in a patient with acute myeloid leukemia.
Topics: Administration, Oral; Adult; Amphotericin B; Antifungal Agents; DNA, Fungal; Exophiala; Female; Humans; Immunocompromised Host; Infusions, Intravenous; Itraconazole; Leukemia, Myeloid, Acute; Mycoses; Neutropenia; Stomatitis | 2003 |
Disseminated infection due to Scedosporium apiospermum in a patient with acute myelogenous leukemia.
Topics: Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Discitis; Drug Therapy, Combination; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Opportunistic Infections; Osteomyelitis; Scedosporium; Sepsis | 2003 |
Acute myelogenous leukemia complicated by acute necrotizing ulcerative gingivitis due to Aspergillus terreus.
Topics: Adolescent; Adult; Aged; Aspergillus; Child; Child, Preschool; Female; Gingivitis, Necrotizing Ulcerative; Humans; Infant; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Treatment Outcome | 2003 |
Intravenous itraconazole for prophylaxis of systemic fungal infections in patients with acute myelogenous leukemia and high-risk myelodysplastic syndrome undergoing induction chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fungemia; Humans; Infusions, Intravenous; Itraconazole; Leukemia, Myeloid, Acute; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myelodysplastic Syndromes; Primary Prevention; Probability; Prognosis; Proportional Hazards Models; Prospective Studies; Remission Induction; Risk Assessment; Survival Analysis; Treatment Outcome | 2004 |
Successful treatment of chronic disseminated candidiasis with caspofungin and itraconazole in a patient with progressive acute leukemia and prolonged neutropenia.
Topics: Adult; Antifungal Agents; Candidiasis; Caspofungin; Chronic Disease; Echinocandins; Female; Humans; Interleukin-2; Itraconazole; Leukemia, Myeloid, Acute; Lipopeptides; Neutropenia; Opportunistic Infections; Peptides; Peptides, Cyclic; Treatment Outcome | 2004 |
[Prophylactic administration of fluconazole and itraconazole in febrile neutropenia associated with hematopoietic malignancy].
Topics: Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Neutropenia; Retrospective Studies | 2006 |
Posaconazole prophylaxis in hematologic cancer.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Mycoses; Opportunistic Infections; Triazoles | 2007 |
Posaconazole prophylaxis in hematologic cancer.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Mycoses; Myelodysplastic Syndromes; Opportunistic Infections; Research Design; Triazoles | 2007 |
Two possible cases of Trichosporon infections in bone-marrow-transplanted children: the first case of T. japonicum isolated from clinical specimens.
Topics: Antibiotics, Antineoplastic; Antifungal Agents; Bone Marrow Transplantation; Child; Fatal Outcome; Female; Humans; Idarubicin; Immunocompromised Host; Infant; Itraconazole; Leukemia, Myeloid, Acute; Male; Mycoses; Neutropenia; Opportunistic Infections; Polymerase Chain Reaction; Trichosporon | 2008 |
Successful treatment of catheter-associated fungemia due to Candida krusei and Trichosporon beigelii in a leukemic patient receiving prophylactic itraconazole.
Topics: Adult; Candidiasis; Catheterization, Central Venous; Fungemia; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Trichosporon | 1995 |
Successful bone marrow transplantation in patients with previous invasive fungal infections: report of four cases.
Topics: Administration, Oral; Adolescent; Adult; Amphotericin B; Aspergillosis; Aspergillus; Bone Marrow Transplantation; Candida; Candidiasis; Female; Fluconazole; Humans; Incidence; Itraconazole; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Lung Diseases; Male; Mycetoma; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pseudallescheria; Recurrence; Risk Factors | 1994 |
Invasive pulmonary aspergillosis prior to BMT in acute leukemia patients does not predict a poor outcome.
Topics: Adolescent; Adult; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Female; Graft Survival; Humans; Immunocompromised Host; Incidence; Itraconazole; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Survival Analysis; Treatment Outcome | 1993 |
Oral aspergillosis in compromised patients.
Topics: Adult; Aged; Aspergillosis; Chemoprevention; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Itraconazole; Leukemia, Biphenotypic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged; Mouth Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1996 |
Cutaneous mucor infection treated with wide excision in two children who underwent marrow transplantation.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Child; Dermatomycoses; Female; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Mucormycosis; Neutropenia; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rhizopus | 1996 |
Itraconazole more bioavailable in solution.
Topics: Antifungal Agents; Graft Rejection; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Leukemia, Myeloid, Acute; Transplantation, Autologous | 1996 |
Early surgical management of invasive gingival aspergillosis in a neutropenic patient with leukemia: a case report.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Female; Fluconazole; Flucytosine; Gingival Diseases; Granulocyte Colony-Stimulating Factor; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myeloid, Acute; Neutropenia | 1997 |
Pulmonary infection caused by Gymnascella hyalinospora in a patient with acute myelogenous leukemia.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Ascomycota; Cytarabine; Drug Resistance, Microbial; Female; Humans; Idarubicin; Itraconazole; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Midwestern United States; Mycological Typing Techniques | 2000 |
Madurella infection in an immunocompromised host.
Topics: Aged; Antifungal Agents; Antimetabolites, Antineoplastic; Cytarabine; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myeloid, Acute; Madurella; Male; Mycetoma | 2000 |
Successful treatment of Aspergillus spondylodiscitis with high-dose itraconazole in a patient with acute myelogenous leukemia.
Topics: Antifungal Agents; Aspergillosis; Discitis; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Treatment Outcome | 2001 |
Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis, Oral; Capsules; Chi-Square Distribution; Chromatography, High Pressure Liquid; Cohort Studies; Fluconazole; Flucytosine; Gingival Diseases; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myeloid, Acute; Leukocyte Count; Neutropenia; Neutrophils; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Risk Factors; Treatment Outcome | 2002 |
Effect of direct infusion of antifungal agent on invasive pulmonary aspergillosis in a patient with acute leukemia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Female; Humans; Itraconazole; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Middle Aged | 2002 |
Fungal Pseudoallescheria boydii lung infiltrates unresponsive to amphotericin B in leukaemic patients.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Humans; Itraconazole; Ketoconazole; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pseudallescheria | 1992 |
Possible failure of itraconazole in preventing fungal infection in a neutropenic leukaemia patient.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Aspergillus niger; Humans; Itraconazole; Ketoconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia | 1992 |
Allogeneic bone marrow transplantation after partial lobectomy for aspergillosis of the lung.
Topics: Adult; Amphotericin B; Aspergillosis; Bone Marrow Transplantation; Female; Humans; Itraconazole; Ketoconazole; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Pneumonectomy | 1988 |